Analyst firms · Raymond James · CDNA
Raymond James CDNA price target and rating history
CareDx Inc. (CDNA) · Health Care
Raymond James rates CareDx Inc. (CDNA) Mkt Perform with a $12 price target, as of its latest action on May 13, 2024. It has published 6 rating actions on CDNA since June 2021, including 1 upgrade and 2 downgrades. Across 3 firms with a CDNA price target in the last 12 months, the median target is $65.
- Current rating
- Mkt Perform
- Price target
- $12
- Median target, all firms
- $65
- Actions on CDNA
- 6
Raymond James price target on CDNA
Every Raymond James rating on CDNA
- May 13, 2024
- Aug 15, 2023
- Mar 3, 2023
- Feb 25, 2022
- Oct 29, 2021
- Jun 28, 2021
How other firms rate CDNA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Piper Sandler | Overweight | $100 | Nov 11, 2026 |
| Canaccord Genuity | Buy | $65 | Sep 2, 2026 |
| Craig-Hallum | Buy | $64 | Aug 3, 2026 |
Questions about Raymond James and CDNA
- What is Raymond James's price target for CDNA?
- Raymond James's latest stated price target for CareDx Inc. (CDNA) is $12, from its action on Aug 15, 2023.
- What is Raymond James's rating on CDNA?
- Raymond James rates CDNA Mkt Perform, a neutral rating, as of May 13, 2024.
- When did Raymond James last change its view on CDNA?
- On May 13, 2024, Raymond James downgrades to Mkt Perform from Outperform.
- How does Raymond James's CDNA target compare with other analysts?
- Across 3 firms with a CDNA price target in the last 12 months, the median target is $65.
More CDNA rating histories
All Raymond James ratingsCDNA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.